Trial Outcomes & Findings for Patient Self-sampling of HPV to Screen for Cervical Cancer (NCT NCT05600283)

NCT ID: NCT05600283

Last Updated: 2026-01-06

Results Overview

Patient-collected vaginal swab HPV results compared with gold standard of clinician-collected cervical swab) to accurately detect HPV infection

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

222 participants

Primary outcome timeframe

Baseline (sample was collected up to 21 days form the date of registration)

Results posted on

2026-01-06

Participant Flow

Group 1: eligible participants enrolled = 89 (98 participants initially deemed eligible; 9 participants declined to participate) Group 2: eligible participants enrolled = 133 (207 participants initially deemed eligible; 74 declined to participate)

Participant milestones

Participant milestones
Measure
Group 1: Self-collected Vaginal Swab Samples at Clinic
Subjects will self-collect a vaginal swab (Evalyn brush) and complete a scheduled standard of care clinician-collected cervical swab Swab kit (COBAS HPV 4800 Assay -Evalyn brush): Patient self-sampling swab kit to collect a vaginal sample for HPV testing Clinician-collection of cervical sample for HPV testing: Speculum exam and collection of a cervical specimen using standard endocervical brush and spatula placed into ThinPrep medium for HPV testing (Evalyn brush)
Group 2: Self-collected Vaginal Swab Samples at Home
Subjects will self-collect a vaginal swab (Evalyn brush) and complete a scheduled standard of care clinician-collected cervical swab Swab kit (COBAS HPV 4800 Assay -Evalyn brush): Patient self-sampling swab kit to collect a vaginal sample for HPV testing Clinician-collection of cervical sample for HPV testing: Speculum exam and collection of a cervical specimen using standard endocervical brush and spatula placed into ThinPrep medium for HPV testing (Evalyn brush)
Overall Study
STARTED
89
133
Overall Study
COMPLETED
79
115
Overall Study
NOT COMPLETED
10
18

Reasons for withdrawal

Reasons for withdrawal
Measure
Group 1: Self-collected Vaginal Swab Samples at Clinic
Subjects will self-collect a vaginal swab (Evalyn brush) and complete a scheduled standard of care clinician-collected cervical swab Swab kit (COBAS HPV 4800 Assay -Evalyn brush): Patient self-sampling swab kit to collect a vaginal sample for HPV testing Clinician-collection of cervical sample for HPV testing: Speculum exam and collection of a cervical specimen using standard endocervical brush and spatula placed into ThinPrep medium for HPV testing (Evalyn brush)
Group 2: Self-collected Vaginal Swab Samples at Home
Subjects will self-collect a vaginal swab (Evalyn brush) and complete a scheduled standard of care clinician-collected cervical swab Swab kit (COBAS HPV 4800 Assay -Evalyn brush): Patient self-sampling swab kit to collect a vaginal sample for HPV testing Clinician-collection of cervical sample for HPV testing: Speculum exam and collection of a cervical specimen using standard endocervical brush and spatula placed into ThinPrep medium for HPV testing (Evalyn brush)
Overall Study
Withdrawal by Subject
3
8
Overall Study
Invalid Vaginal Swab
2
2
Overall Study
Missing Clinician Collection
3
6
Overall Study
Screen Failure
1
2
Overall Study
Sample Lost in Transit
1
0

Baseline Characteristics

Patient Self-sampling of HPV to Screen for Cervical Cancer

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Group 1: Self-collected Vaginal Swab Samples at Clinic
n=81 Participants
Subjects will self-collect a vaginal swab (Evalyn brush) and complete a scheduled standard of care clinician-collected cervical swab Swab kit (COBAS HPV 4800 Assay -Evalyn brush): Patient self-sampling swab kit to collect a vaginal sample for HPV testing Clinician-collection of cervical sample for HPV testing: Speculum exam and collection of a cervical specimen using standard endocervical brush and spatula placed into ThinPrep medium for HPV testing (Evalyn brush)
Group 2: Self-collected Vaginal Swab Samples at Home
n=127 Participants
Subjects will self-collect a vaginal swab (Evalyn brush) and complete a scheduled standard of care clinician-collected cervical swab Swab kit (COBAS HPV 4800 Assay -Evalyn brush): Patient self-sampling swab kit to collect a vaginal sample for HPV testing Clinician-collection of cervical sample for HPV testing: Speculum exam and collection of a cervical specimen using standard endocervical brush and spatula placed into ThinPrep medium for HPV testing (Evalyn brush)
Total
n=208 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=37 Participants
0 Participants
n=56 Participants
0 Participants
n=82 Participants
Age, Categorical
Between 18 and 65 years
81 Participants
n=37 Participants
127 Participants
n=56 Participants
208 Participants
n=82 Participants
Age, Categorical
>=65 years
0 Participants
n=37 Participants
0 Participants
n=56 Participants
0 Participants
n=82 Participants
Sex: Female, Male
Female
81 Participants
n=37 Participants
127 Participants
n=56 Participants
208 Participants
n=82 Participants
Sex: Female, Male
Male
0 Participants
n=37 Participants
0 Participants
n=56 Participants
0 Participants
n=82 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
4 Participants
n=37 Participants
5 Participants
n=56 Participants
9 Participants
n=82 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
0 Participants
n=37 Participants
0 Participants
n=56 Participants
0 Participants
n=82 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
77 Participants
n=37 Participants
122 Participants
n=56 Participants
199 Participants
n=82 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=37 Participants
0 Participants
n=56 Participants
0 Participants
n=82 Participants
Race (NIH/OMB)
Asian
0 Participants
n=37 Participants
2 Participants
n=56 Participants
2 Participants
n=82 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=37 Participants
1 Participants
n=56 Participants
1 Participants
n=82 Participants
Race (NIH/OMB)
Black or African American
0 Participants
n=37 Participants
3 Participants
n=56 Participants
3 Participants
n=82 Participants
Race (NIH/OMB)
White
72 Participants
n=37 Participants
114 Participants
n=56 Participants
186 Participants
n=82 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=37 Participants
0 Participants
n=56 Participants
0 Participants
n=82 Participants
Race (NIH/OMB)
Unknown or Not Reported
9 Participants
n=37 Participants
7 Participants
n=56 Participants
16 Participants
n=82 Participants
Region of Enrollment
United States
81 participants
n=37 Participants
127 participants
n=56 Participants
0 participants
n=82 Participants

PRIMARY outcome

Timeframe: Baseline (sample was collected up to 21 days form the date of registration)

Patient-collected vaginal swab HPV results compared with gold standard of clinician-collected cervical swab) to accurately detect HPV infection

Outcome measures

Outcome measures
Measure
Group 1: Self-collected Vaginal Swab Samples at Clinic
n=79 Participants
Subjects will self-collect a vaginal swab (Evalyn brush) and complete a scheduled standard of care clinician-collected cervical swab Swab kit (COBAS HPV 4800 Assay -Evalyn brush): Patient self-sampling swab kit to collect a vaginal sample for HPV testing Clinician-collection of cervical sample for HPV testing: Speculum exam and collection of a cervical specimen using standard endocervical brush and spatula placed into ThinPrep medium for HPV testing (Evalyn brush)
Group 2: Self-collected Vaginal Swab Samples at Home
n=115 Participants
Subjects will self-collect a vaginal swab (Evalyn brush) and complete a scheduled standard of care clinician-collected cervical swab Swab kit (COBAS HPV 4800 Assay -Evalyn brush): Patient self-sampling swab kit to collect a vaginal sample for HPV testing Clinician-collection of cervical sample for HPV testing: Speculum exam and collection of a cervical specimen using standard endocervical brush and spatula placed into ThinPrep medium for HPV testing (Evalyn brush)
Concordance of Patient-collected and Clinician-collected Samples to Detect HPV Infection
HPV18
99 Total Percentage Agreement
95 Total Percentage Agreement
Concordance of Patient-collected and Clinician-collected Samples to Detect HPV Infection
Other HPV
86 Total Percentage Agreement
89 Total Percentage Agreement
Concordance of Patient-collected and Clinician-collected Samples to Detect HPV Infection
HPV16
98 Total Percentage Agreement
94 Total Percentage Agreement

SECONDARY outcome

Timeframe: Baseline (sample was collected up to 21 days form the date of registration)

Population: Survey results are reported for all participants who completed vaginal self-collection and returned the survey, even if the self-collection sample was deemed invalid or clinician sample was not received.

Assessed by survey question "Overall, how acceptable was it for you to collect the sample using the Evalyn® brush?," which was answered on a 4-point scale (completely unacceptable, unacceptable, acceptable, or completely acceptable).

Outcome measures

Outcome measures
Measure
Group 1: Self-collected Vaginal Swab Samples at Clinic
n=81 Participants
Subjects will self-collect a vaginal swab (Evalyn brush) and complete a scheduled standard of care clinician-collected cervical swab Swab kit (COBAS HPV 4800 Assay -Evalyn brush): Patient self-sampling swab kit to collect a vaginal sample for HPV testing Clinician-collection of cervical sample for HPV testing: Speculum exam and collection of a cervical specimen using standard endocervical brush and spatula placed into ThinPrep medium for HPV testing (Evalyn brush)
Group 2: Self-collected Vaginal Swab Samples at Home
n=126 Participants
Subjects will self-collect a vaginal swab (Evalyn brush) and complete a scheduled standard of care clinician-collected cervical swab Swab kit (COBAS HPV 4800 Assay -Evalyn brush): Patient self-sampling swab kit to collect a vaginal sample for HPV testing Clinician-collection of cervical sample for HPV testing: Speculum exam and collection of a cervical specimen using standard endocervical brush and spatula placed into ThinPrep medium for HPV testing (Evalyn brush)
Patient-reported Acceptability of Using the Evalyn Brush
Completely unacceptable
0 Participants
0 Participants
Patient-reported Acceptability of Using the Evalyn Brush
Unacceptable
0 Participants
1 Participants
Patient-reported Acceptability of Using the Evalyn Brush
Acceptable
15 Participants
37 Participants
Patient-reported Acceptability of Using the Evalyn Brush
Completely acceptable
66 Participants
88 Participants

Adverse Events

Group 1: Self-collected Vaginal Swab Samples at Clinic

Serious events: 0 serious events
Other events: 2 other events
Deaths: 0 deaths

Group 2: Self-collected Vaginal Swab Samples at Home

Serious events: 0 serious events
Other events: 1 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
Group 1: Self-collected Vaginal Swab Samples at Clinic
n=81 participants at risk
Subjects will self-collect a vaginal swab (Evalyn brush) and complete a scheduled standard of care clinician-collected cervical swab Swab kit (COBAS HPV 4800 Assay -Evalyn brush): Patient self-sampling swab kit to collect a vaginal sample for HPV testing Clinician-collection of cervical sample for HPV testing: Speculum exam and collection of a cervical specimen using standard endocervical brush and spatula placed into ThinPrep medium for HPV testing (Evalyn brush)
Group 2: Self-collected Vaginal Swab Samples at Home
n=127 participants at risk
Subjects will self-collect a vaginal swab (Evalyn brush) and complete a scheduled standard of care clinician-collected cervical swab Swab kit (COBAS HPV 4800 Assay -Evalyn brush): Patient self-sampling swab kit to collect a vaginal sample for HPV testing Clinician-collection of cervical sample for HPV testing: Speculum exam and collection of a cervical specimen using standard endocervical brush and spatula placed into ThinPrep medium for HPV testing (Evalyn brush)
Product Issues
Participant inserted self-collection device with cap on (did not remove cap)
2.5%
2/81 • Number of events 2 • Baseline (at the time of swab collection). Participants collected swab samples up to 21 days from the time of enrollment.
0.00%
0/127 • Baseline (at the time of swab collection). Participants collected swab samples up to 21 days from the time of enrollment.
Product Issues
Device damaged during mailing to patient
0.00%
0/81 • Baseline (at the time of swab collection). Participants collected swab samples up to 21 days from the time of enrollment.
0.79%
1/127 • Number of events 1 • Baseline (at the time of swab collection). Participants collected swab samples up to 21 days from the time of enrollment.

Additional Information

Dr. Kathy MacLaughlin

Mayo Clinic

Phone: 507-266-4648

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place